Table 4

Summary of factors associated with choice of etanercept over monoclonal TNFis in patients wth axSpA (summary of multivariable model)

VariableWaldP valueOR95% CI for OR
BASDAI score5.9410.0151.1581.029–1.304
BASFI score0.3150.5771.0280.932–1.135
Education (university degree vs lower)1.0980.2950.8360.597–1.169
AAU (any)35.266<0.0010.1540.083–0.286
IBD (Crohn’s disease or ulcerative colitis)13.853<0.0010.2960.156–0.562
  • AAU, acute anterior uveitis; axSpA, axial spondyloarthritis; BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; BASFI, Bath Ankylosing Spondylitis Functional Index; IBD, inflammatory bowel disease; TNFi, tumour necrosis factor-inhibitor.